Monteverde Law Firm Investigates Multiple Acquisition Cases
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: Globenewswire
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the acquisition of Penumbra, Inc. by Boston Scientific Corporation, where shareholders are expected to receive either 3.8721 shares of Boston Scientific or $374 in cash per share, aiming to secure fair compensation for investors.
- RAPT Transaction Details: In the acquisition of RAPT Therapeutics, Inc. by GSK plc, shareholders are anticipated to receive $58 in cash per share, providing direct cash returns that enhance investor confidence in the transaction.
- Nathan's Famous Acquisition: Nathan's Famous, Inc. is set to be acquired by Smithfield Foods, Inc., with shareholders expected to receive $102 in cash per share, which significantly boosts shareholder trust and reflects the value of their investment.
- Lisata Transaction Terms: In the acquisition of Lisata Therapeutics, Inc. by Smithfield Foods, Inc., shareholders will receive $4 in cash per share along with a non-transferable contingent value right, potentially allowing for additional payments under certain conditions, indicating a commitment to shareholder interests.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on NATH
About NATH
Nathan’s Famous, Inc. is a licensor, wholesaler and retailer of products marketed under its Nathan’s Famous brand, including its Nathan’s World Famous Beef Hot Dogs. The Company distributes its products in 50 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, Guam, and 20 foreign countries. The Branded Product Program segment is engaged in the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. The Product licensing segment includes royalties, from licensing a range of its branded products, including its hot dogs, sausage and corned beef products, frozen French fries and additional products, through retail grocery channels and club stores throughout the United States. The Restaurant operations segment is engaged in the sale of its products at Company-owned restaurants and earns fees and royalties from its franchised restaurants, including its virtual kitchens.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investigation of Investor Rights: SkyWater and Others
- Legal Investigation Launched: Halper Sadeh LLC is investigating SkyWater Technology, Inc. (NASDAQ: SKYT) regarding its sale to IonQ for $15.00 in cash and $20.00 in IonQ stock, potentially violating fiduciary duties to shareholders and impacting their rights.
- Shareholder Rights Protection: Nathan’s Famous, Inc. (NASDAQ: NATH) is being sold to Smithfield Foods, Inc. for $102.00 per share in cash, and Halper Sadeh LLC may seek increased consideration for shareholders to ensure fair compensation.
- Lisata Therapeutics Transaction Review: Lisata Therapeutics, Inc. (NASDAQ: LSTA) is selling to Kuva Labs, Inc. for $4.00 per share in cash plus two non-tradeable rights, with Halper Sadeh LLC assessing the potential impact on shareholders to safeguard their legal rights.
- No Upfront Legal Fees: Halper Sadeh LLC offers legal services on a contingency fee basis, encouraging shareholders to reach out to discuss their rights and options, ensuring they receive due compensation in cases of securities fraud and corporate misconduct.

Continue Reading
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the acquisition of Penumbra, Inc. by Boston Scientific Corporation, where shareholders are expected to receive either 3.8721 shares of Boston Scientific or $374 in cash per share, aiming to secure fair compensation for investors.
- RAPT Transaction Details: In the acquisition of RAPT Therapeutics, Inc. by GSK plc, shareholders are anticipated to receive $58 in cash per share, providing direct cash returns that enhance investor confidence in the transaction.
- Nathan's Famous Acquisition: Nathan's Famous, Inc. is set to be acquired by Smithfield Foods, Inc., with shareholders expected to receive $102 in cash per share, which significantly boosts shareholder trust and reflects the value of their investment.
- Lisata Transaction Terms: In the acquisition of Lisata Therapeutics, Inc. by Smithfield Foods, Inc., shareholders will receive $4 in cash per share along with a non-transferable contingent value right, potentially allowing for additional payments under certain conditions, indicating a commitment to shareholder interests.

Continue Reading








